IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Assertio Holdings, Inc. provides medicines in neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the. treatment of migraine, nausea, photophobia, and phonophobia.
Manufacturing
Pharmaceutical Products
$84.77M
20
Daniel A. Peisert
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = ASRT ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$ASRT Assertio Holdings, Inc. | 71 | 80 | 98 | 98 | 100.3x | 1.6x | -20.2% | -6.7% | 72.0% | -16.2% | -23.5% | 58.9% | 0.0% | 202.0x | $85M | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
Assertio Holdings, Inc. (ASRT) receives a "Buy" rating with a composite score of 71.4/100. It ranks #73 out of 7,333 stocks in our coverage universe and carries a 4-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
Daniel A. Peisert
Chief Executive Officer
Labor Force
20
80
23
40
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for ASRT
Outperforming peers — winners tend to keep winning over 3-12 months
Trading at a discount to fundamentals — favorable entry valuation
High profitability & efficiency — strong quality floor supports entry
Average volatility — neutral timing signal
Aggressive spending — empire-building risk, dilutive growth
Top-rated overall — multiple factors aligned for strong entry
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for ASRT.
View All RatingsYOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Conservative accounting — High cash conversion efficiency
Material decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 80 | 90 | -10DRAG |
| MOMENTUM | 98 | 100 | -2NEUTRAL |
| VALUATION | 98 | 99 | -1NEUTRAL |
| INVESTMENT | 23 | 6 | +17ALPHA |
| STABILITY | 40 | 19 | +21ALPHA |
| SHORT INT | 42 | 36 | +6ALPHA |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC 1028.5% vs WACC 7.1% (spread +1021.4%)
GM 72% vs sector 43%, OM -16% vs sector 1%
Capital turnover 44.32x, R&D intensity 1.1%
Rev growth 59%, 6yr history
Interest coverage 14.9x, Net debt/EBITDA 0.1x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Assertio Holdings, Inc. receives a Buy rating with a composite score of 71.4/100 and 4 out of 5 stars, ranking #73 of 7,333 stocks in our universe. ASRT displays a favorable combination of factors that positions it above the majority of the market. While not without risk, the quantitative profile supports a constructive outlook.
ASRT earns a quality score of 80/100, indicating above-average business quality. The company reports a return on equity of -20.2% (sector avg: -2.5%), gross margins of 72.0% (sector avg: 42.5%), net margins of -23.5% (sector avg: -0.2%). Companies in this tier generally demonstrate consistent profitability and efficient capital deployment, though they may face some competitive pressure.
From a valuation perspective, ASRT scores an exceptional 98/100, indicating the stock trades at a deep discount relative to its fundamentals. Key valuation metrics include a P/E ratio of 100.33x, an EV/EBITDA of 1.65x, a P/B ratio of 0.72x. A value score this high suggests the market may be significantly underpricing the company's earnings power, assets, or cash flow generation.
Assertio Holdings, Inc.'s investment score of 23/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 58.9% vs. a sector average of 5.9% and a return on assets of -6.7% (sector: -0.1%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
Assertio Holdings, Inc. (ASRT) is exhibiting exceptional momentum with a score of 98/100, placing it among the strongest trending stocks in the market. Revenue growth stands at 58.9% year-over-year, while a beta of 0.53 reflects its sensitivity to broader market moves. Stocks with momentum scores this high have historically outperformed over the following 3–12 months, suggesting ASRT may continue to benefit from strong institutional interest and positive price trends.
ASRT's stability score of 40/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of 0.53 and a debt-to-equity ratio of 202.00x (sector avg: 0.2x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
The short interest score of 42/100 for ASRT suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include elevated leverage (D/E: 202.00x), micro-cap liquidity risk. With a $85M market cap (micro-cap), Assertio Holdings, Inc. may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
Assertio Holdings, Inc. is a micro-cap company in the Manufacturing sector, ranked #39 of 50 in its sector (22nd percentile) and #73 of 7,333 overall (99th percentile). Key comparisons include ROE of -20.2% trailing the -2.5% sector median and operating margins of -16.2% below the 1.3% sector average. This bottom-quartile standing highlights significant competitive headwinds within the Manufacturing space.
Want professional-grade coverage on ASRT?
Access Premium Terminal →Quant Factor Profile
Key factor gap
Momentum (98) vs Investment (23) — closing this gap could shift the rating.
RANK #39 OF 50 IN INDUSTRIALS
EV/EBITDA 86% BELOW SECTOR MEDIAN (FAVORABLE)
ROE 715% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 69% ABOVE SECTOR MEDIAN (FAVORABLE)
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate Assertio Holdings, Inc. (ASRT) as a Buy with a composite score of 71.4/100 at a current price of $11.97. The stock scores above average across the majority of our six quantitative factors and ranks #73 out of 7,333 stocks in our universe, reflecting a favorable risk-reward profile.
The rating is primarily driven by strength in momentum (98th percentile) and value (98th percentile), which together account for the majority of the composite score. Offsetting weakness in investment (23th percentile) and stability (40th percentile) tempers our overall conviction. We assign a Wide Moat rating (70/100), High uncertainty, and Poor capital allocation.
Key items to watch: balance sheet deleveraging progress; sustainability of the current growth rate; the path to profitability. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
Assertio Holdings, Inc. holds a lower-quartile position (#39 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 71.4/100 places it at rank #73 in our full 7,333-stock universe. At $85M in market capitalization, Assertio Holdings, Inc. is a small-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
The near-term outlook is constructive, with revenue growing at 59% and momentum in the 98th percentile confirming positive market sentiment and institutional accumulation. The combination of strong top-line growth and favorable price dynamics suggests the company is executing well on its growth strategy. Investment factor at the 23th percentile indicates reinvestment patterns that investors should monitor for sustainability.
The margin cascade tells an important story: gross margins of 72% (+29.5pp vs sector) narrow to operating margins of -16% (-17.5pp vs sector) and net margins of -23.5%, yielding a gross-to-net conversion rate of -33%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $11.97, Assertio Holdings, Inc. appears undervalued relative to its fundamentals. Our value factor score of 98/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The stock screens as attractively priced on a majority of these measures, suggesting the market may be underappreciating the underlying fundamentals.
The stock currently trades at a P/E of 100.3x (a 351% premium to the sector median of 22.3x), EV/EBITDA of 1.6x (discounted to peers), P/B of 0.7x, P/S of 0.6x. The above-sector P/E multiple suggests the market is pricing in superior growth or quality, which our analysis partially supports given strong quality metrics.
The stock's Buy rating (composite score 71.4/100) reflects broad-based quantitative strength, placing it in the top 20% of our 7,333-stock universe.
Gross margins of 72% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Revenue growth of 59% confirms the business is expanding its addressable market — growth at this level typically supports multiple expansion and attracts institutional capital.
A value factor score of 98/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
Positive momentum (98th percentile) indicates institutional accumulation and favorable technical dynamics that tend to persist in the intermediate term.
We assign a High uncertainty rating to Assertio Holdings, Inc.. Key risk factors include significant leverage (202% debt-to-equity), current negative profitability (net margin -23.5%), low beta of 0.53 — while defensive, this may indicate limited upside participation in bull markets. The wide range of potential outcomes widens our fair value estimate and increases the possibility of permanent capital impairment. Investors considering this name should size positions accordingly and demand a meaningful margin of safety before initiating.
Specific risk factors that inform our assessment include: significant leverage (202% debt-to-equity); current negative profitability (net margin -23.5%); low beta of 0.53 — while defensive, this may indicate limited upside participation in bull markets; elevated valuation multiple (P/E 100.3x) that leaves limited margin for error. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 40th percentile and quality factor at the 80th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 72% provide a buffer against cost pressures. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile warrants caution and disciplined position management.
We rate Assertio Holdings, Inc.'s capital allocation as Poor. Key concerns include low returns on equity (-20.2%), elevated leverage (202% D/E), negative profitability, weak asset returns (ROA -6.7%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — Assertio Holdings, Inc. significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, Assertio Holdings, Inc. receives a Buy rating with a composite score of 71.4/100 (rank #73 of 7,333). Our quantitative framework assigns a Wide Moat (70/100, trend: stable), High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 68/100.
Our analysis supports a constructive view on Assertio Holdings, Inc.. The combination of a wide competitive moat, high uncertainty, and poor capital allocation creates a risk-reward profile that favors accumulation at current levels. We recommend investors consider adding this name to portfolios aligned with the stock's risk profile.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We assign Assertio Holdings, Inc. a Wide Moat rating with a composite moat score of 70/100. The ROIC-WACC spread of +1021.4% is the primary signal of economic value creation. This places the company among an elite group of businesses with deep, durable competitive advantages that we expect to persist for 20 years or more. The score reflects strength across multiple competitive dimensions, with economic value creation (17.5/20) as the leading contributor.
The strongest moat sources are economic value creation (17.5/20) and financial resilience (17.4/20). ROIC 1028.5% vs WACC 7.1% (spread +1021.4%). Interest coverage 14.9x, Net debt/EBITDA 0.1x. These pillars form the core of Assertio Holdings, Inc.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (6.4/20) and margin superiority (13.1/20). Capital turnover 44.32x, R&D intensity 1.1%. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect Assertio Holdings, Inc.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 72% providing a solid profitability foundation, robust top-line growth of 59% expanding the revenue base. The margin cascade from 72% gross to -16% operating to -23.5% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that the profit engine is high-quality and likely sustainable, with the quality factor at the 80th percentile.
The margin profile shows gross margins of 72%, operating margins of -16%, net margins of -23.5%. Return metrics include ROE of -20.2% and ROA of -6.7%. Relative to the Manufacturing sector, gross margins are 29.5 percentage points above the sector median of 43%, and ROE of -20.2% compares to a sector median of -2.5%.
The balance sheet reflects high leverage with D/E of 202%, which may limit financial flexibility, revenue growth of 59%. The sector median D/E is 0%, putting Assertio Holdings, Inc. at higher leverage than the typical peer. Elevated leverage in combination with the current margin profile warrants close monitoring for any deterioration in debt-servicing capacity.
A P/E of 100.3x leaves little room for execution misses — any earnings disappointment could trigger a sharp multiple compression.
Elevated leverage (202% D/E) amplifies downside risk and limits management's financial flexibility in adverse scenarios.
Thin net margins of -23.5% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
Assertio Holdings (NASDAQ: ASRT) has seen a 28% share price increase over the last month, yet its revenues remain muted. The company's low price-to-sales (P/S) ratio of 0.5x, significantly below the Pharmaceuticals industry average, reflects concerns over its revenue performance, which has grown slower than most peers and is forecasted to decline by 1.4% annually over the next three years. This poor outlook on revenue growth justifies the low P/S ratio, making a strong share price rise unlikely in the near future despite recent gains.
Short interest in Assertio Holdings, Inc. (NASDAQ:ASRT) significantly decreased by 92.8% to 285,110 shares as of December 31st, representing about 4.6% of shares sold short. Institutional ownership is substantial at 48.96%, with several firms increasing their stakes. Despite a mixed fundamental and analyst picture, with recent EPS and revenue beats but negative net margin, analysts generally maintain a "Moderate Buy" rating with an average price target of $30.63.
Assertio Holdings, Inc. announced that it has regained compliance with Nasdaq's minimum bid price requirement, fulfilling Nasdaq Listing Rule 5550(a)(2). This follows a previous non-compliance issue and a one-for-fifteen reverse stock split implemented in December 2025. The pharmaceutical company's stock currently trades at $9.32, with H.C. Wainwright recently raising its price target to $35.00.
Assertio Holdings, Inc. has successfully regained compliance with Nasdaq's minimum bid price rule after completing a one-for-fifteen reverse stock split in December 2025. This move ensures the pharmaceutical company maintains its Nasdaq listing. The compliance follows a strong Q3 2025 earnings report and a raised price target from H.C. Wainwright.
Assertio Holdings, Inc. (NASDAQ: ASRT) announced it has regained compliance with Nasdaq's minimum bid price rule, following a successful reverse stock-split in December 2025. This ensures the company's common stock maintains a minimum bid price of $1.00 per share, keeping its listing on the exchange. CEO Mark Reisenauer emphasized the efficiency of this action while preserving capital allocation flexibility.
Above 50MA
37.18%
Net New Highs
+51081